India to United States: Esomeprazole Export Trade Route
India has recorded 867 verified shipments of Esomeprazole exported to United States, representing a combined trade value of $94.9M USD. This corridor is served by 23 active Indian exporters, with an average shipment value of $109.5K USD. The leading Indian exporter is CIPLA LIMITED, which accounts for 56% of total export value with 176 shipments worth $52.7M USD. On the buying side, CIPLA USA INC UPS SUPPLY CHAIN SOLU is the largest importer in United States with $42.4M USD in purchases. The top 3 suppliers — CIPLA LIMITED, DR.REDDY'S LABORATORIES LTD, BIOCON PHARMA LIMITED — together control 71% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Esomeprazole corridor is one of India's established pharmaceutical export routes, with 867 shipments documented worth a combined $94.9M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 56% of all export value, reflecting the consolidated nature of India's esomeprazole manufacturing sector.
Across 23 active suppliers, the average shipment value stands at $109.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with esomeprazole's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 25.7%, placing it at rank #15 among India's top esomeprazole export destinations globally.
On the import side, key buyers of Indian esomeprazole in United States include CIPLA USA INC UPS SUPPLY CHAIN SOLU, CIPLA USA INC UPS SUPPLY CHAIN SOL, DR REDDYS LABORATORIES INC and 68 others. CIPLA USA INC UPS SUPPLY CHAIN SOLU is the single largest importer with 135 shipments valued at $42.4M USD.
Route Characteristics
- Average transit17 days
- Peak seasonQ2
- Primary modeSea freight
- Top portHYDERABAD ICD
Market Position
- Global rank#15
- Annual growth+25.7%
- Demand growth+23.5%
- Regulatory ease85/100
Top 10 Indian Esomeprazole Exporters to United States
Showing top 10 of 23 Indian suppliers exporting Esomeprazole to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CIPLA LIMITED Avg $299.3K per shipment | 176 | $52.7M | 55.5% |
| 2 | DR.REDDY'S LABORATORIES LTD Avg $49.5K per shipment | 159 | $7.9M | 8.3% |
| 3 | BIOCON PHARMA LIMITED Avg $48.1K per shipment | 140 | $6.7M | 7.1% |
| 4 | ANNORA PHARMA PRIVATE LIMITED Avg $36.8K per shipment | 151 | $5.6M | 5.9% |
| 5 | MYLAN LABORATORIES LIMITED Avg $140.8K per shipment | 29 | $4.1M | 4.3% |
| 6 | DR REDDYS LABORATORIES LIMITED Avg $63.4K per shipment | 50 | $3.2M | 3.3% |
| 7 | ZYDUS LIFESCIENCES LIMITED Avg $230.7K per shipment | 12 | $2.8M | 2.9% |
| 8 | DR REDDY S LABORATORIES LIMITED Avg $157.7K per shipment | 15 | $2.4M | 2.5% |
| 9 | TORRENT PHARMACEUTICALS LTD Avg $172.6K per shipment | 11 | $1.9M | 2.0% |
| 10 | CADILA HEALTHCARE LTD Avg $368.9K per shipment | 5 | $1.8M | 1.9% |
This table shows the top 10 of 23 Indian companies exporting esomeprazole to United States, ranked by total trade value. The listed exporters are: CIPLA LIMITED, DR.REDDY'S LABORATORIES LTD, BIOCON PHARMA LIMITED, ANNORA PHARMA PRIVATE LIMITED, MYLAN LABORATORIES LIMITED, DR REDDYS LABORATORIES LIMITED, ZYDUS LIFESCIENCES LIMITED, DR REDDY S LABORATORIES LIMITED, TORRENT PHARMACEUTICALS LTD, CADILA HEALTHCARE LTD. CIPLA LIMITED is the dominant supplier with 176 shipments worth $52.7M USD, giving it a 56% market share. The top 3 suppliers together account for 71% of the total trade value on this route.
Showing top 10 of 23 total Indian exporters on the India to United States Esomeprazole export route.
Top 10 Esomeprazole Importers in United States
Showing top 10 of 71 known buyers in United States receiving Esomeprazole shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian esomeprazole in United States include CIPLA USA INC UPS SUPPLY CHAIN SOLU, CIPLA USA INC UPS SUPPLY CHAIN SOL, DR REDDYS LABORATORIES INC, BIOCON PHARMA INC, EVERSANA LIFE SCIENCE SERVICES, among 71 total buyers. The largest importer is CIPLA USA INC UPS SUPPLY CHAIN SOLU, accounting for $42.4M USD across 135 shipments — representing 45% of all esomeprazole imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CIPLA USA INC UPS SUPPLY CHAIN SOLU | 135 | $42.4M | 44.7% |
| 2 | CIPLA USA INC UPS SUPPLY CHAIN SOL | 38 | $10.0M | 10.5% |
| 3 | DR REDDYS LABORATORIES INC | 49 | $5.3M | 5.6% |
| 4 | BIOCON PHARMA INC | 110 | $5.2M | 5.5% |
| 5 | EVERSANA LIFE SCIENCE SERVICES | 12 | $4.3M | 4.5% |
| 6 | MYLAN PHARMACEUTICALS INC, | 20 | $3.7M | 3.9% |
| 7 | TORRENT PHARMA INC, | 10 | $1.8M | 1.9% |
| 8 | NORTHSTAR DISTRIBUTION CENTER 8912 | 71 | $1.7M | 1.8% |
| 9 | TO THE ORDER OF | 43 | $1.6M | 1.7% |
| 10 | DR. REDDYS LABORATORIES, INC | 25 | $1.5M | 1.6% |
Showing top 10 of 71 Esomeprazole importers in United States on this route.
Top 10 Esomeprazole Formulations Imported by United States
Showing top 10 of 505 product formulations shipped on the India to United States Esomeprazole route, ranked by trade value
United States imports a wide range of esomeprazole formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — ESOMEPRAZOLE MAGNESIUM FOR DELAYED RELEASE ORAL SUSPENSION 40MG NDC NO. 69097-529-34 ANDA NO. 211751 (INV.QTY.3240 — accounts for $7.1M USD across 2 shipments. There are 505 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ESOMEPRAZOLE MAGNESIUM FOR DELAYED RELEASE ORAL SUSPENSION 40MG NDC NO. 69097-529-34 ANDA NO. 211751 (INV.QTY.3240 | 2 | $7.1M | 7.5% |
| 2 | ESOMEPRAZOLE MAGNESIUM FOR DELAYED RELEASE ORAL SUSPENSION 40MG NDC NO. 69097-529-34 ANDA NO. 211751(INV.QTY.3216 | 1 | $6.8M | 7.2% |
| 3 | ESOMEPRAZOLE MAGNESIUM FOR DELAYED RELEASE ORAL SUSPENSION 10MG;NDC NO.:69097-527-34; ANDA NO.:211752PACK SIZE:30X3.2GM | 1 | $6.1M | 6.4% |
| 4 | ESOMEPRAZOLE MAGNESIUM FOR DELAYED RELEASE ORAL SUSPENSION 10MG;NDC NO.:69097-527-34;(PS:30X3.2GMX3252 PACK=97560 NOS) | 1 | $6.1M | 6.4% |
| 5 | ESOMEPRAZOLE MAGNESIUM FOR DELAYED RELEA | 14 | $3.0M | 3.2% |
| 6 | ESOMEPRAZOLE MAGNESIUM CAPS | 42 | $1.9M | 2.0% |
| 7 | ESOMEPRAZOLE MAGNESIUM FOR DELAYED RELEASE ORAL SUSPENSION 10MG NDC NO. 69097-527-34 ANDA NO. 211752 30 X 3.2 GM | 6 | $1.3M | 1.4% |
| 8 | ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES USP 40 MG 90BT 1056 PACKS | 1 | $1.1M | 1.2% |
| 9 | ESOMEPRAZOLE MAGNESIUM FOR DELAYED RELEASE ORAL SUSPENSION 40MG ESOMEPRAZOLE MAGNESIUM DR 40MG - 12708 PACx1x30PACKETS | 1 | $1.0M | 1.1% |
| 10 | ESOMEPRAZOLE MAGNESIUM FOR DELAYEDRELEASE ORAL SUSPENSION 40MG ; NDC NO.: 69097-529-34; ANDA No.: 211751 (IN | 3 | $927.4K | 1.0% |
Showing top 10 of 505 Esomeprazole formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 81%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
HYDERABAD ICD handles the highest volume with 214 shipments. Transit time averages 17 days by sea.
Market Dynamics
India's esomeprazole exports to United States are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 176 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 23 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — CIPLA LIMITED, DR.REDDY'S LABORATORIES LTD, BIOCON PHARMA LIMITED — together account for 71% of total trade value on this route. The average shipment value of $109.5K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as esomeprazole magnesium for delayed release oral suspension 40mg ndc no. 69097-529-34 anda no. 211751(inv.qty.3216 and esomeprazole magnesium for delayed release oral suspension 10mg;ndc no.:69097-527-34; anda no.:211752pack size:30x3.2gm, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, CIPLA USA INC UPS SUPPLY CHAIN SOLU is the largest importer with 135 shipments worth $42.4M USD — representing 45% of all esomeprazole imports from India on this route. A total of 71 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $94.9M
- Avg. Shipment
- $109.5K
- Suppliers
- 23
- Buyers
- 71
- Transit (Sea)
- ~17 days
- Annual Growth
- +25.7%
Related Analysis
Reverse Direction
United States → India — Esomeprazole (Import)Other Esomeprazole Routes
Unlock the Full India to United States Esomeprazole Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 867 shipments on this route.
Frequently Asked Questions — India to United States Esomeprazole Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Esomeprazole to United States?
The leading Indian exporters of Esomeprazole to United States are CIPLA LIMITED, DR.REDDY'S LABORATORIES LTD, BIOCON PHARMA LIMITED. CIPLA LIMITED holds the largest market share at approximately 56% of total trade value on this route.
Q What is the total value of Esomeprazole exports from India to United States?
India exports Esomeprazole to United States worth approximately $94.9M USD across 867 recorded shipments. The average value per shipment is $109.5K USD.
Q Which ports does India use to ship Esomeprazole to United States?
The most active port of origin is HYDERABAD ICD with 214 shipments. Indian exporters primarily use sea freight for this route, with 81% of shipments going by sea and 27% by air.
Q How long does shipping take from India to United States for Esomeprazole?
The average transit time for Esomeprazole shipments from India to United States is approximately 17 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to United States Esomeprazole trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 25.7% with demand growth tracking at 23.5%. The route is ranked #15 among India's top Esomeprazole export destinations globally.
Q How many suppliers are active on the India to United States Esomeprazole route?
There are currently 23 active Indian suppliers exporting Esomeprazole to United States. The market is moderately concentrated with CIPLA LIMITED accounting for 56% of total shipment value.
Q Who are the main importers of Esomeprazole from India in United States?
The leading importers of Indian Esomeprazole in United States include CIPLA USA INC UPS SUPPLY CHAIN SOLU, CIPLA USA INC UPS SUPPLY CHAIN SOL, DR REDDYS LABORATORIES INC, BIOCON PHARMA INC, EVERSANA LIFE SCIENCE SERVICES. CIPLA USA INC UPS SUPPLY CHAIN SOLU is the largest buyer with 135 shipments worth $42.4M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Esomeprazole.
- 2.Supplier/Buyer Matching: 23 Indian exporters and 71 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 867 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
867 Verified Shipments
23 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists